期刊文献+

川崎病与不完全川崎病的临床特征分析

Clinical features of complete Kawasaki disease versus incomplete Kawasaki disease
原文传递
导出
摘要 目的:比较川崎病与不完全川崎病临床特点及实验室检查结果的差异,为临床早期识别、早期诊断提供依据。方法:回顾性分析甘肃省妇幼保健院2014年1月至2018年12月确诊的川崎病(217例)和不完全川崎病(103例)患儿的临床资料,比较两组临床症状特征及实验室检查指标。结果:两组患儿发热发生率均为100.0%,但不完全川崎病组发热时间为(8.97±1.76)d,长于川崎病组的(6.60±1.01)d(t=7.68,P<0.05);不完全川崎病组结膜充血、口唇皲裂、杨梅舌及手指硬肿红斑发生率分别为82.5%(84/103)、66.9%(69/103)、21.4%(22/103)、23.3%(24/103),均低于川崎病组的94.9%(206/217)、76.9%(167/217)、75.1%(163/217)、81.1%(176/217)(χ^(2)=14.71、7.09、82.76、99.58,均P<0.05),多形性皮疹、肛周脱皮发生率分别为76.7%(79/103)、33.9%(35/103),均明显高于川崎病组的64.9%(141/217)、23.5%(51/217)(χ^(2)=4.47、3.90,均P<0.05)。不完全川崎病组患儿伴有消化系统和呼吸系统症状较川崎病组多见(P<0.05)。不完全川崎病组C-反应蛋白[(67.56±23.35)mg/L]较川崎病组[(53.91±25.06)mg/L]高(t=2.46,P<0.05),白细胞计数、血小板、B型脑钠肽较川崎病组低(t=2.00、2.34、4.69,均P<0.05)。不完全川崎病组患儿冠状动脉扩张或小型冠状动脉瘤及心包积液的发生率均高于川崎病组(χ^(2)=6.70、12.87,均P<0.05)。结论:不完全川崎病患儿发热时间长,在主要临床特征不明显的患儿中,需注意鉴别,及早诊治不完全川崎病,降低冠状动脉病变的发生率。 Objective To investigate the clinical features and laboratory examination results of complete Kawasaki disease(CKD)versus incomplete Kawasaki disease(IKD).Methods The clinical data of children with complete Kawasaki disease(CKD group,n=217)and incomplete Kawasaki disease(IKD group,n=103)who received treatment in Gansu Provincial Maternity and Child-care Hospital from January 2014 to December 2018 were retrospectively analyzed.Clinical symptom features and laboratory examination indexes were compared between the two groups.Results The incidence of fever in both groups was 100.0%,but the fever time in the IKD group was(8.97±1.76)days,which was significantly longer than(6.60±1.01)days in the CKD group(t=7.68,P<0.05).The incidences of conjunctival hyperemia,chapped lips,bayberry tongue and finger sclerosis and erythema in the IKD group were 82.5%(84/103),66.9%(69/103),21.4%(22/103),and 23.3%(24/103),which were significantly lower than 94.9%(206/217),76.9%(167/217),75.1%(163/217),and 81.1%(176/217)in the CKD group(χ^(2)=14.71,7.09,82.76,99.58,all P<0.05).The incidences of polymorphic rash and perianal peeling in the IKD group were 76.7%(79/103)and 33.9%(35/103),respectively,which were significantly higher than 64.9%(141/217)and 23.5%(51/217)in the CKD group(χ^(2)=4.47,3.90,both P<0.05).Digestive and respiratory symptoms were more common in the IKD group than in the CKD group(P<0.05).C-reactive protein level in the IKD group was(67.56±23.35)mg/L,which was significantly higher than(53.91±25.06)mg/L in the CKD group(t=2.46,P<0.05),while white blood cell count,platelet count,and B-type brain natriuretic peptide level in the IKD group were significantly lower than those in the CKD group(t=2.00,2.34,4.69,all P<0.05).The incidences of coronary artery dilation/small coronary artery aneurysm,and pericardial effusion in the IKD group were greater than those in the CKD group(χ^(2)=6.70,12.87,both P<0.05).Conclusion Children with IKD have a long time of fever.In children without obvious clinical features,attention should b
作者 张伟 宁锋锋 朱生东 王莉 Zhang Wei;Ning Fengfeng;Zhu Shengdong;Wang Li(Department of Pediatric Comprehensive Medicine,Gansu Provincial Maternity and Child-care Hospital,Lanzhou 730050,Gansu Province,China;Department of Anesthesia and Surgery,Gansu Provincial Maternity and Child-care Hospital,Lanzhou 730050,Gansu Province,China)
出处 《中国基层医药》 CAS 2023年第9期1346-1350,共5页 Chinese Journal of Primary Medicine and Pharmacy
关键词 黏膜皮肤淋巴结综合征 体征和症状 发热 结膜充血 口唇皲裂 杨梅舌 C反应蛋白质 儿童 病例对照研究 Mucocutaneous lymph node syndrome Signs and symptoms Fever Conjunctival hyperemia Chapped lips Bayberry tongue C-Reactive protein Child Case-control studies
  • 相关文献

参考文献8

二级参考文献46

  • 1张伟,李秋,赵晓东,唐雪梅,王晓刚,王墨,吴道奇,欧茜,杨锡强.川崎病发生冠状动脉病变危险因素的Logistic回归分析[J].中国实用儿科杂志,2006,21(1):51-53. 被引量:40
  • 2黄敏.川崎病随访方案(试行)[J].临床儿科杂志,2006,24(5):427-428. 被引量:18
  • 3覃丽君,王宏伟,胡秀芬,刘清军,施虹,隈远祥,陈全景,程佩萱.静脉注射不同剂量丙种球蛋白治疗川崎病的临床研究[J].中华儿科杂志,2006,44(12):891-895. 被引量:40
  • 4无,赵晓东(整理),杜忠东(整理).川崎病专题讨论会纪要[J].中华儿科杂志,2007,45(11):826-830. 被引量:149
  • 5Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease : a statement for health professionals from the Co mmittee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on CardiOvascular Disease in the Young. American Heart Association [J]. Pediatrics, 2004,114(6) : 1708-1733. 被引量:1
  • 6Mentz RJ, Felker M. Natriuretic peptide-guided therapy for heart failure [ J ]. Circ J, 2011,75:2031-2037. 被引量:1
  • 7Kawamura T, Wago M, Kawaguchi H, et al. Plasma brain natfiuretic peptide concentrations in patients with Kawasaki disease [J]. Pediatr [nt, 2000,42(3) :241-248. 被引量:1
  • 8Adjagba PM, Desjardins L, Foumier A, et al. N-terminal probrain natriuretic peptide in acute Kawasaki disease correlates with coronary artery involvement [ J ]. Cardiol Young, 2014,10 (29) : 1-8. 被引量:1
  • 9Sakurai Y, Takatsuka H, Onaka M, et al. Persistent endothelial damage after intravenous i mmunoglobulin therapy in Kawasaki disease [J]. Int Arch Allergy I mmunol, 2014,165 (2) : 111 - 118. 被引量:1
  • 10Mahfouz RA, Alzaiat A, Gad M. Association of aortic stiffness to brain natriuretic peptide in children before and after device closure of patent ductusarteriosus [J ]. J Saudi Heart Assoc, 2015,27 ( 1 ) : 23-30. 被引量:1

共引文献117

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部